Medical Services


In the management of our specialist doctors, we are all progressing together, using all the latest medical approaches and continuing to be informed at every step of your treatment.


By using advanced technological equipment and laboratory applications, your reproductive cells are welcomed in our laboratory in the most suitable environment conditions until the day of transfer.

Our Quality Policy

In international standards, clinical and laboratory applications are being used to maximize the success of your treatment.

Transparent and Reliable Service

In your treatment process, you will be welcomed with clear and honest information at every stage, before and after every procedure, and regardless of the result, you will leave without any question marks in your mind.


The feedback from our patients is very important to us. We expect your views and suggestions, pleasure and complaints during and after the treatment period.

Our Team

The path to parenting can sometimes be difficult and long. Be comfortable; The Liv Hospital IVF Team is transforming the dreams of the couples in this challenging journey into reality with high success rates.


The case that pregnancy did not occur at the end of a year despite of unprotected and enough often intercourse is called infertility (sterility). 85 percent of the couples achieve pregnancy in one year, and 93 percent within two years. The remaining group is considered as infertile and need assisted reproduction technologies.

So roughly, we encounter the problem of infertility in 15-20% of the population.


The factor that prevents pregnancy can be identified in 85-90 percent of infertile couples in today’s technology. Approximately 40 percent of these are due women, while 40 percent due to men. All parameters are normal in the remaining 20 percent group, so we do not find a tangible cause in couples in this group with our knowledge at this moment. This case is called “unexplained infertility”.

The most important factor affecting the success of IVF treatment is the age of the woman and the woman’s egg reserve. In particular, the number and quality of eggs in the reserves in women over 38 years begin to decline seriously; pregnancy rates over age 40 falls to 30% even with IVF. The age of 45 (with some exceptions) is considered as ceiling age in order to achieve pregnancy with treatments in women according to currently accepted criteria. Some of problems due to the women arise necessity for surgical operation prior to IVF treatment, while some problems may change the treatment protocol to be applied. For example, congenital or subsequently acquired intrauterine disorders are first corrected by surgery then treatment is started, or treatment protocols and medication doses will be adjusted accordingly in cases that ovarian reserve of the woman more or less than expected depending on the age of the woman.


introduction of department

Liv Hospital, which adds new miracles to life with treatments of gynecologic oncology, high-risk pregnancy and in vitro fertilization, is addressing all processes of women’s health from the adolescence. Liv Hospital Obstetrics and Gynecology Department brings physicians specialized in branches such as Gynecologic Oncology, Adolescent Health, Menopause, Risk Pregnancy and IVF together and offers personalized treatments.

Liv Hospital Obstetrics and Gynecology Department is targeting the highest success rate of treatment for all diseases related to women’s health, changes experienced before and after pregnancy, in menopause period, and gynecological cancer cases, which are the fearful dreams of every woman.

Robotic and laparoscopic surgeries, which are today’s latest technology, are used in the treatment of gynecological diseases in Liv Hospital. Robotic surgery is carried out especially in the treatment of uterine and ovarian cancers at Liv Hospital in 2014 and the duration of the treatment was shortened by 50 percent with this type of surgical method. The rates of surgical complications, infection and reoperation were realized as 0% in surgeries performed in 2014 for the treatment of uterine and ovarian cancers that are common in women.